Triple
T17925482
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Order of the Republic |
E448182
|
entity |
| Predicate | notableRecipient |
P108
|
FINISHED |
| Object | Zhong Nanshan |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Zhong Nanshan | Statement: [Order of the Republic, notableRecipient, Zhong Nanshan]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Zhong Nanshan Context triple: [Order of the Republic, notableRecipient, Zhong Nanshan]
-
A.
Tu Youyou
Tu Youyou is a Chinese pharmaceutical chemist and Nobel laureate renowned for discovering the antimalarial drug artemisinin, which has saved millions of lives worldwide.
-
B.
Dr. Lui Cheng
Dr. Lui Cheng is a fictional character named in association with Morgan, likely appearing in a narrative work such as a film, television series, or novel.
-
C.
Chen Zhu
Chen Zhu is a prominent Chinese hematologist and molecular biologist who served as China's Minister of Health and is known for his contributions to leukemia research and public health reform.
-
D.
Kun Huang
Kun Huang was a prominent Chinese physicist and crystallographer known for his influential work in solid-state physics and lattice dynamics.
-
E.
Wei-ming Tu
Wei-ming Tu is a prominent Chinese philosopher and scholar of Confucianism known for his influential work on New Confucian thought and comparative philosophy.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Zhong Nanshan Target entity description: Zhong Nanshan is a renowned Chinese pulmonologist and epidemiologist celebrated for his leading roles in combating the SARS outbreak and the COVID-19 pandemic in China.
-
A.
Tu Youyou
Tu Youyou is a Chinese pharmaceutical chemist and Nobel laureate renowned for discovering the antimalarial drug artemisinin, which has saved millions of lives worldwide.
-
B.
Dr. Lui Cheng
Dr. Lui Cheng is a fictional character named in association with Morgan, likely appearing in a narrative work such as a film, television series, or novel.
-
C.
Chen Zhu
Chen Zhu is a prominent Chinese hematologist and molecular biologist who served as China's Minister of Health and is known for his contributions to leukemia research and public health reform.
-
D.
Kun Huang
Kun Huang was a prominent Chinese physicist and crystallographer known for his influential work in solid-state physics and lattice dynamics.
-
E.
Wei-ming Tu
Wei-ming Tu is a prominent Chinese philosopher and scholar of Confucianism known for his influential work on New Confucian thought and comparative philosophy.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b9f79d14819095540856928f0e25 |
completed | April 10, 2026, 8:51 a.m. |
| NER | Named-entity recognition | batch_69e4a54e03588190b36a9bb88e4085de |
completed | April 19, 2026, 9:50 a.m. |
Created at: April 10, 2026, 10:20 a.m.